CROs

Trial sponsors say CROs need to own their mistakes and take responsibility
Trial sponsors say CROs need to own their mistakes and take responsibility
Clinical Trials Arena
CROs
clinical trials
Flag link:
A leading CRO’s chief exec on why a ‘brave new world’ of clinical research is here
A leading CRO’s chief exec on why a ‘brave new world’ of clinical research is here
Pharma Voice
Worldwide Clinical Trials
CROs
R&D
clinical trials
Flag link:
Why Lilly is trying new strokes to persevere against pain
Why Lilly is trying new strokes to persevere against pain
Fierce Biotech
Eli Lilly
chronic pain
CROs
Flag link:
10 Trends and Statistics for Clinical Trials in 2023
10 Trends and Statistics for Clinical Trials in 2023
Xtalks
clinical trials
R&D
CROs
Flag link:
Galapagos, following Sanofi’s playbook, offloads French R&D site to drug discovery CRO
Galapagos, following Sanofi’s playbook, offloads French R&D site to drug discovery CRO
Fierce Biotech
Galapagos
Sanofi
R&D
CROs
NovAliX
Flag link:
Sponsors need to maintain robust oversight of CROs to avoid FDA enforcement action
Sponsors need to maintain robust oversight of CROs to avoid FDA enforcement action
RAPS.org
FDA
regulatory
CROs
Flag link:
Growing demand for organ-on-a-chip services prompt CN Bio expansion
Growing demand for organ-on-a-chip services prompt CN Bio expansion
Fierce Biotech
CN Bio
CROs
organ-on-a-chip
drug discovery
Flag link:
Europe to suspend about 100 generic drugs after uncovering data 'irregularities' at Indian CRO
Europe to suspend about 100 generic drugs after uncovering data 'irregularities' at Indian CRO
Endpoints
Europe
India
CROs
generics
Flag link:
Charles River diving deeper into AI drug development in partnership with Valo Health
Charles River diving deeper into AI drug development in partnership with Valo Health
Fierce Biotech
Charles River Labs
artificial intelligence
Valo Health
CROs
Flag link:
Three Companies Join Forces to Become Centricity Research, North America’s Largest lntegrated Research Site Organization
Three Companies Join Forces to Become Centricity Research, North America’s Largest lntegrated Research Site Organization
CP Wire
R&D
Centricity Research
LMC Manna
IACT Health
True North Clinical Research
CROs
Flag link:
CROs embracing tech to decentralize trials and speed enrollment as regulators show support 'with their feet'
CROs embracing tech to decentralize trials and speed enrollment as regulators show support 'with their feet'
Fierce Biotech
CROs
clinical trials
decentralized clinical trials
Flag link:
Three Companies Join Forces to Become Centricity Research, North America’s Largest lntegrated Research Site Organization
R&D
Centricity Research
LMC Manna
IACT Health
True North Clinical Research
CROs
Flag link:
CRO owner pleads guilty to obstructing FDA investigation into falsified clinical trial data
CRO owner pleads guilty to obstructing FDA investigation into falsified clinical trial data
Endpoints
legal
CROs
GSK
clinical trials
falsified data
Flag link:
New Medtech Accelerator to Launch in 2022
New Medtech Accelerator to Launch in 2022
Medical Devices and Diagnostics Industry
Proxima Clinical Research
Medtech
devices
CROs
Texas
accelerators
Flag link:
Curia to acquire Integrity Bio
Curia to acquire Integrity Bio
Biopharma Reporter
Curia
Integrity Bio
CROs
CDMOs
M&A
Flag link:
LMC Manna Research Branches into Dermatology
LMC Manna Research Branches into Dermatology
CP WIre
LMC Manna
dermatology
clinical trials
CROs
Flag link:
LMC Manna Research Branches into Dermatology
LMC Manna
dermatology
clinical trials
CROs
Flag link:
Feds charge another CRO staffer with faking data in a GlaxoSmithKline pediatric asthma study
Feds charge another CRO staffer with faking data in a GlaxoSmithKline pediatric asthma study
Endpoints
GSK
asthma
clinical trial
fraud
CROs
Flag link:
Another big CRO deal in the works? Thermo Fisher in talks to acquire PPD for $15B+ — report
Another big CRO deal in the works? Thermo Fisher in talks to acquire PPD for $15B+ — report
Endpoints
ThermoFisher Scientific
PPD
M&A
CROs
Flag link:
The CRO megamerger is back as Icon snaps up PRA Health for $12B
The CRO megamerger is back as Icon snaps up PRA Health for $12B
Fierce Biotech
M&A
CROs
Icon Biosciences
PRA Health
Flag link:

Pages